Clin2
NCT05179499Possibly a fitRecruiting

Early norepinephrine for low blood pressure in sepsis

Sepsis

Treatments studied

Part of Infections clinical trials.

This Phase 3 trial tests whether starting a medicine called norepinephrine early can improve outcomes for adults with sepsis (a serious body-wide response to infection) and low blood pressure. You might be considered if you’re very early in hospital care and meet specific blood pressure and lactate tests.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
1,006 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • Be over 18 years old
  • Be in hospital within the last 12 hours because of suspected or confirmed infection
  • Have low blood pressure right now (systolic under 90 or mean arterial pressure under 65) within about 1 hour of screening
  • Have an elevated lactate level (more than 2 mmol/L) measured around 2 hours before eligibility, if possible
  • You have not already had a lot of IV fluids (more than 1500 ml) before screening

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07343206Recruiting
Early norepinephrine for sepsis with low blood pressure

This trial tests whether giving a medicine called norepinephrine early and adjusting the dose quickly can help people with sepsis who have very low blood pressure. It is for adults who are diagnosed within the last 3 hours and who have not already received this medicine.

Bangkok Noi, Bangkok
NCT06478797Not yet recruiting· Phase 2
Early blood pressure support for children with sepsis

This study tests whether giving a medicine to support blood pressure (inotrope) early, along with extra fluids, can help children with sepsis and shock. It may be an option for children whose shock is not improving after initial fluids.

Santa Fe
NCT07716956Not yet recruiting
Magnesium and norepinephrine for septic shock

This trial tests whether raising magnesium levels in the blood to the upper end of normal can reduce the amount of norepinephrine (a medicine to raise blood pressure) needed in patients with septic shock who are already on steroids.

Alexandria, Alexandria Governorate
NCT06319248Recruiting· Phase 2
Midodrine to treat sepsis and reduce IV vasopressors

This trial tests if the oral medication midodrine can help wean patients with sepsis off IV vasopressors faster, potentially reducing ICU stays and complications.

Scottsdale, Arizona
NCT05836272Recruiting· Phase 4
Early norepinephrine for low blood pressure in sepsis

This trial tests whether starting norepinephrine early can improve outcomes for adults with sepsis who have low blood pressure. It may help stabilize circulation sooner and reduce complications from severe infection.

Tunis
NCT06464510Recruiting· Phase 3
Treating sepsis with norepinephrine plus early vasopressin

This trial tests whether giving a second medicine called vasopressin early (along with norepinephrine) helps people with sepsis and low blood pressure better than waiting to use vasopressin only if norepinephrine doesn't work. It may improve blood pressure control and reduce the need for strong medicines.

Caxias do Sul, Rio Grande do Sul

Hear when a new Sepsis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.